论文部分内容阅读
目的:探讨孟鲁司特联合沙美特罗替卡松治疗支气管哮喘的临床效果。方法:选择自2016年1月到2017年1月我院收治的86名支气管哮喘患者为研究对象,并将其分为观察组与对照组。对照组应用沙美特罗替卡松进行治疗,观察组采取孟鲁司特与沙美特罗替卡松联合治疗,对两组患者的哮喘控制情况以及治疗效果进行分析。结果:在治疗后两组患者的呼吸控制情况都得到了良好的改善,但是两组患者的呼吸控制情况没有明显差异(P>0.05);在治疗后,观察组的治疗总有效率大于对照组,且差异具有统计学意义(P<0.05)。结论:应用孟鲁司特与善美特罗替卡松联合治疗支气管哮喘,具有良好的临床效果。
Objective: To investigate the clinical effect of montelukast combined with salmeterol and fluticasone in the treatment of bronchial asthma. Methods: From January 2016 to January 2017, 86 patients with bronchial asthma admitted to our hospital were selected as study subjects and divided into observation group and control group. The control group was treated with salmeterol and fluticasone. The observation group was treated with montelukast and salmeterol and fluticasone. The control and treatment of asthma in both groups were analyzed. Results: After treatment, the respiratory control of both groups was well improved, but there was no significant difference between the two groups in respiratory control (P> 0.05). After treatment, the total effective rate of the observation group was higher than that of the control group , And the difference was statistically significant (P <0.05). Conclusion: The combination of montelukast and pramipexole combined treatment of bronchial asthma, has a good clinical effect.